US Patent Issued to QURIENT on Aug. 4 for "Compounds having cyclin-dependent kinase(CDK)-inhibitory function" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,288, issued on Aug. 4, was assigned to QURIENT Co. LTD (Gyeonggi-Do, South Korea).

"Compounds having cyclin-dependent kinase(CDK)-inhibitory function" was invented by Kiyean Nam (Gyeonggi-do, South Korea), Jaeseung Kim (Seoul, South Korea), Dongsik Park (Gyeonggi-do, South Korea), Mooyoung Seo (Gyeonggi-do, South Korea), Yeejin Jeon (Gyeonggi-do, South Korea) and Donghoon Yu (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds having cyclin-dependent kinase (CDK)-inhibitory functions and/or pharmaceutically acceptable salts thereof, the use of these compounds as pharmaceutically active ag...